This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol. .
Clinicaltrials into cannabis’ potential as an opioid replacement are well underway in South Africa. We are currently recruiting patients, and data-capturing all the questionnaires and feedback from the patients for the live study. Quite frankly, the clinicaltrials couldn’t have come at a better time.
House lawmakers introduced The Medical Cannabis Research Act of 2019 (HR 601), to facilitate federally-approved clinicaltrials involving cannabis. At the state level, patients in Ohio and Oklahoma now have access to medical cannabis, as sales began in both states this week. Additionally, a bipartisan coalition of U.S.
Research on the endocannabinoid system is one of the most promising avenues for new therapeutics in medicine at the moment, however regulations are constantly shifting beneath the feet of operators and their ability to serve patients depends on their capacity to navigate a changing landscape of governance.
Some hemp cultivation is permitted in Japan, but on a relatively very small scale. Japan does not have a medical cannabis program and does not allow the use of cannabis for patients seeking to treat a medical condition. Stigma is a major issue facing cannabis fans, patients, and all those who support legalization in Japan.
Patients with Parkinson’s disease also frequently suffer from mood issues such as apathy and depression. For those unfamiliar, GB Sciences is a technology company that merges plant biology, cultivation, and post-production processes in order to optimize safe, consistent medical cannabis treatment. What is GB Sciences?
In December of 2023, the country recently made a new move towards reform that could stimulate the cannabidiol (CBD) industry and provide many patients, such as those with epilepsy , with access to potentially life-changing medical treatments. and Europe to treat severe epilepsy, as well as other medical conditions.
The government does allow cultivation of cannabis in special facilities for research purposes, but experts involved complain that it is inadequate. The court told the DEA to consider rescheduling cannabis after a slew of patients and proponents claimed the agency was denying them desperately-needed relief.
(NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is pleased to announce that it has signed an agreement to begin scientific clinicaltrials globally. About Flora Growth Corp.
Denmark is already leading the way by launching a Big Pharma modelled 4-year medical marijuana trial in early 2018, following a unanimous vote in Parliament. We gave the option to foreign companies to cultivate in Denmark.”. This ground-breaking trial has full parliamentary support, and will be evaluated in mid-2020.
Both Colorado and Oregon allow patients to take psilocybin under the supervision of regulated and licensed “healing centers.” Smith cited results from clinicaltrials showing that MDMA holds promise in the treatment of PTSD. Legal Colorado and Oregon are the only states allowing legal therapeutic psilocybin use today.
federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. You don’t take that opium poppy and ask a patient to rub it on their lip for morphine. Fortunately, the U.S. territories. This means that U.S. federal law.
The uptick has been represented in the patient count, as well. Although we note the early stage of the sector in Australia and the associated volatility of a nascent industry, over the same period patient numbers domestically have continued to soar,” Bell and Smith wrote in their note. Learn to profit from cannabis companies.
Possession, sale, and cultivation of cannabis are all considered criminal offenses. However, in 2019, the Jordanian government announced its plans to conduct clinicaltrials on the use of cannabis for medical purposes. Is weed legal in Jordan? Recreational cannabis use is illegal in Jordan.
. – ‘No definitive evidence’ – British charity Versus Arthritis recommends patients contemplating CBD should consult their doctor beforehand, and also wants more work done to understand its impact. ” [link].
The research will focus on the optimisation of breeding and cultivating processes and the extraction of material to assess their efficacy of medical cannabis on prostate, melanoma and other cancer cells. All intellectual property from the trials will be owned by MGC, which is funding the research. Here’s the press release.
According to CAMH’s lead investigator, clinicaltrials suggest that psilocybin, combined with psychotherapy, can produce “ sustained antidepressant effects” in individuals living with severe depression.
Many patients are turning to cannabis for insomnia relief, seeking its potential to improve sleep quality and duration. In this article, we explore the role of medical marijuana in addressing insomnia, examining its effectiveness, safety considerations, legal aspects, and practical considerations for patients and healthcare providers.
Cannatrek’s Seed to Patient business model combines cutting edge cultivation expertise and world class manufacturing practices to deliver high quality medicinal cannabis oil formulations and medicinal strains of dried flowers at a significantly lower cost to patients and retailers.
CANNABIS CULTURE – The results are now in after the first-ever legal clinicaltrial into the use of cannabis to treat PTSD, but did the DEA’s rules taint the outcome? That’s what most providers are worried about when their patients with PTSD decide to try cannabis.”.
All Optimi mushroom products are grown from the Company’s world-leading psilocybin genetic bank and are grown in EU-GMP compliant clean rooms that ensure sterile cultivation and undergo almost 300 different analytical tests post-harvest. The harvest includes the following psilocybin-containing mushroom strains: Koh Samui. Penis Envy.
“We’re actively working toward developing new genetics to work on efficacy and assist the patients in Israel still operating with our nurse-run clinics in order to better provide the right dosage and strains for the patients who are referred to us by the Ministry of Health,” Stephen Gardner, Tikun Olam’s chief marketing officer, tells Freedom Leaf.
A new cultivation facility that is hoping to change lives with psychedelic mushrooms had their grand opening on Friday in Princeton, after being awarded a dealer’s license in February by Health Canada. The psilocybin mushrooms are headed to clinicaltrials, drug companies and medical facilities. “I’m
Enacted in 2015, the program was designed to provide a narrow avenue for patients suffering from qualifying conditions to access low-THC cannabis under the supervision of qualified healthcare professionals. Physician’s Prescription: Patients must obtain a prescription from a qualified physician registered with the TCUP.
This new bill allows broad hemp cultivation. Prior to receiving FDA approval, Epidiolex underwent a number of clinicaltrials establishing the medical efficacy of CBD. ”, our first instinct is to remain patients that CBD is CBD. CBD is also a favorite among insomnia patients.
The number of patients approved for the use of medical cannabis in Israel has increased steadily, reaching over 100,000 in January 2022. We will soon also produce the first batches for upcoming clinicaltrials of MediCane later in the year.”. The company launched its manufacturing facility in Kfar Saba in 2020.
By early 2016, Australia’s federal parliament passed a bill that laid the groundwork for cannabis to be legally cultivated and manufactured for medicinal and scientific purposes here. The clinicaltrials and the standard of production could lead the world.”. Fitzsimons seized the opportunity.
Domestic Cultivation and Products. . One issue on the table is the decision for large-scale domestic cultivation. While a handful of patients currently are immune from prosecution for growing their own cannabis, large-scale grow operations are non-existent. Brazil’s case is no different. Opposition. .
The consultation covers proposed licensing, cultivation, manufacturing and product standards, and a prescription and enforcement regime. But even if there is no doubt that a regulated market would provide a safer environment for access, we argue that there could be a potential cost to patient safety. From trial to market.
Marijuana use is associated with a reduction in the use of attention-deficit hyperactivity disorder (ADHD) medications in patients diagnosed with the syndrome, according a new study published in the journal Rambam Maimonides and first reported on by NORML. score, n=30) or high ASRS score (i.e. ?3.18 score, n=29) subgroups.
Medical Cannabis Australia, the company she founded, just obtained its cultivation and manufacture licenses from the Office of Drug Control (ODC) in April of this year. For the first time, he was a patient and not a criminal. They presented case studies about patients who have had incredible success from their cannabis treatments.
This is expected to increase cannabis cultivation to suffice the growing demand. In recent years, numerous countries have legalized medical cannabis, but its prescription is dependent on the demand of the patient and physician’s preference. Global Legal Cannabis Industry: Number of ClinicalTrials, By Region.
This year, we are completing the second Phase 3 clinicaltrial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. On May 3, 2021, our study of MDMA-assisted therapy for PTSD achieved successful results for patients with severe, chronic PTSD.
While selling the cannabis cultivation and oil production business, GB Sciences retained the benefit of Wellcana Plus’s 50% interest in intellectual property developed under the Master Research and Development Agreement. John Poss, CEO of GB Sciences, stated, “We think the transaction is a win for everyone.
The programme aims to investigate mechanisms of action of cannabis-based medicinal products related to several clinical applications including pain and cancer, as well as characterise cannabis-based medicinal products in disease models with particular focus of chronic pain, spasticity and cancer. About EMMAC.
Australian marijuana stocks have cratered and work on one huge growing project is on hold, but three other big cannabis cultivation projects are pushing onwards, raising the prospect of oversupply and an eventual shakeout in the industry, one expert says. Here’s the story about these unicorn like grow projects. Yahoo News reports.
The country legalized medical cannabis in 2016, but patients in the country have long criticized the program as too restrictive, and access to cannabis-based medicines remains behind that of many other legal cannabis jurisdictions. A doctor who applies to the TGA on behalf of a patient must provide a clinical justification.
The Board has noted with concern recent reports regarding the legalisation of cannabis possession, use and cultivation in small amounts in the Australian Capital Territory, effective 31 January 2020.
The first Australian company to be licensed to cultivate and manufacture medicinal marijuana has praised the Federal Government’s plan to allow exports of cannabis-based medicines. “It’s very important from our perspective to ensure that the Australian patient gets medicine first. The ABC reported back in 2018.
The bill would expand patients’ access to the necessary treatment for more than 50 conditions, including cancer and post-traumatic stress disorder (PTSD), neurological diseases, and chronic pain of neuropathic origin. “; 4) Article 11 shall be worded as follows: ” Article 11.
That said, these state-specific schemes would not include the possibility of relegating the plant’s sale solely to pharmacies and/or exclusively to those patients who possess a doctor’s prescription because marijuana would still lack FDA approval as a medicine and, therefore, it would not be categorized as a Schedule II through V substance.
This was accomplished via the SVG Bureau of Standards creating a Scientific Research License that allows for the cultivation, processing, import/export of psychedelic compounds for medicinal purposes and scientific research. The eventual trials would target PTSD, addiction, alcoholism, depression, and anxiety. and Europe.
The Australian Capital Territory ( ACT ) voted to legalise the personal possession and cultivation of cannabis. The ACT Legislative Assembly voted to legalise the personal possession and cultivation of cannabis on 25 September 2019. Final Report Reviewing Framework for Medicinal Cannabis Cultivation, Production and Manufacture.
The burgeoning cannabis industry is poised to revolutionize patient care and the leisure industry and these changes are creating new international ecosystems that will have massive impact, from local farm workers to the world’s largest corporations. CNBX) is a U.S
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content